Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 6, 2014, Pages 818-819

  Stahl, Mark C ^a   Harris, Caitlin K ^b   Matto, Sulaiman ^b   Bernstein, Jonathan A ^c  

^a WRIGHT PATTERSON AIR FORCE BASE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; DANAZOL; DIPHENHYDRAMINE; ECALLANTIDE; FEXOFENADINE; FRESH FROZEN PLASMA; GESTAGEN; HYDROXYCHLOROQUINE; ICATIBANT; METHYLPREDNISOLONE; MONTELUKAST; PREDNISONE; RANITIDINE; SALAZOSULFAPYRIDINE; TRANEXAMIC ACID; BRADYKININ; IMMUNOLOGIC FACTOR; PEPTIDE;

ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; BREATHING DISORDER; CASE REPORT; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; DYSPHAGIA; EMERGENCY WARD; EPINEPHRINE AUTOINJECTOR; FACE EDEMA; FAMILY HISTORY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IDIOPATHIC NONHISTAMINERGIC ANGIOEDEMA; INTENSIVE CARE UNIT; INTUBATION; LABORATORY TEST; MEDICAL HISTORY; MOUTH EDEMA; OVARY POLYCYSTIC DISEASE; PERIORBITAL EDEMA; PLASMA TRANSFUSION; PROPHYLAXIS; TONGUE EDEMA; TREATMENT DURATION; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; ANGIOEDEMA; DRUG COMBINATION; IMMUNOLOGY; REMISSION; TREATMENT OUTCOME;

ADULT; ANGIOEDEMA; BRADYKININ; COMPLEMENT C1 INHIBITOR PROTEIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; PEPTIDES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84923260089     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.05.006     Document Type: Article

References (8)

1. Bernstein J.A. Hereditary angioedema with normal C1 inhibitor: an evolving diagnosis. Allergy Asthma Proc 2012, 33:S143-S144.
2. Berry A., Firszt R. Successful treatment of idiopathic angioedema with ecallantide. JAllergy Clin Immunol Pract 2013, 1:297-298.
3. Dy T.B., Rasheed M., Parikh P., Bernstein L. Resolution of an acute attack of idiopathic angioedema with ecallantide. Ann Allergy Asthma Immunol 2013, 111:224-226.
4. Del Corso I., Puxeddu I., Sardano E., Geraci S., Breggia M., Rocchi V., et al. Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant. Ann Allergy Asthma Immunol 2012, 108:460-461.
5. Colás C., Montoiro R., Fraj J., Garcés M., Cubero J.L., Caballero T. Nonhistaminergic idiopathic angioedema: clinical response to icatibant. JInvestig Allergol Clin Immunol 2012, 22:520-521.
6. Cicardi M., Bergamaschini L., Zingale L.C., Gioffré D., Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med 1999, 106:650-654.
7. Zingale L.C., Beltrami L., Zanichelli A., Maggioi L., Pappalardo E., Cicardi B., et al. Angioedema without urticaria: a large clinical survey. Can Med Assoc J 2006, 175:1065-1070.
8. Bork K., Wulff K., Hardt J., Witzke G., Staubach P. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. JAllergy Clin Immunol 2009, 124:129-134.